Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway

S Herbertz, JS Sawyer, AJ Stauber… - Drug design …, 2015 - Taylor & Francis
Transforming growth factor-beta (TGF-β) signaling regulates a wide range of biological
processes. TGF-β plays an important role in tumorigenesis and contributes to the hallmarks …

Novel therapies emerging in oncology to target the TGF-β pathway

BG Kim, E Malek, SH Choi, JJ Ignatz-Hoover… - Journal of hematology & …, 2021 - Springer
The TGF-β signaling pathway governs key cellular processes under physiologic conditions
and is deregulated in many pathologies, including cancer. TGF-β is a multifunctional …

Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma

V Hernandez–Gea, S Toffanin, SL Friedman, JM Llovet - Gastroenterology, 2013 - Elsevier
Hepatocellular carcinoma (HCC) is the most common primary liver tumor and the third
greatest cause of cancer-related death worldwide, and its incidence is increasing. Despite …

Network modeling of TGFβ signaling in hepatocellular carcinoma epithelial-to-mesenchymal transition reveals joint sonic hedgehog and Wnt pathway activation

SN Steinway, JGT Zañudo, W Ding, CB Rountree… - Cancer research, 2014 - AACR
Epithelial-to-mesenchymal transition (EMT) is a developmental process hijacked by cancer
cells to leave the primary tumor site, invade surrounding tissue, and establish distant …

Dysregulation of growth factor signaling in human hepatocellular carcinoma

K Breuhahn, T Longerich, P Schirmacher - Oncogene, 2006 - nature.com
Dysregulation of pleiotropic growth factors, receptors and their downstream signaling
pathway components represent a central protumorigenic principle in human …

Transforming growth factor β and the liver

MD Bissell, D Roulot, J George - Hepatology, 2001 - journals.lww.com
Building of tissue, whether in the embryo or after injury in the adult, requires coordination of
several important cellular actions including fibrogenesis, proliferation, migration, contraction …

CD44s Regulates the TGF-β–mediated mesenchymal phenotype and is associated with poor prognosis in patients with hepatocellular carcinoma

K Mima, H Okabe, T Ishimoto, H Hayashi, S Nakagawa… - Cancer research, 2012 - AACR
The prognosis for individuals diagnosed with hepatocellular carcinoma (HCC) remains poor
because of the high frequency of invasive tumor growth, intrahepatic spread, and …

Role of transforming growth factor beta in cancer

B Pasche - Journal of cellular physiology, 2001 - Wiley Online Library
Transforming growth factor beta (TGF‐β) is an effective and ubiquitous mediator of cell
growth. The significance of this cytokine in cancer susceptibility, cancer development and …

Current perspectives on the tumor microenvironment in hepatocellular carcinoma

C Santhakumar, EJ Gane, K Liu… - Hepatology International, 2020 - Springer
Hepatocellular carcinoma (HCC) is a heterogeneous inflammation-driven malignancy,
which, despite significant advances in management, continues to portend a poor prognosis …

[PDF][PDF] Epigenetic regulation of cancer stem cell marker CD133 by transforming growth factor‐β

H You, W Ding, CB Rountree - Hepatology, 2010 - Wiley Online Library
Hepatocellular carcinoma (HCC) is the third leading cause of cancer mortality worldwide.
CD133, a transmembrane glycoprotein, is an important cell surface marker for both stem …